diabetes - Nursing Case Study

Pathophysiology

• Insulin deficiency/resistance: In Type 1 diabetes, the pancreas fails to produce insulin due to autoimmune destruction of beta cells. In Type 2, cells become resistant to insulin's effects, often due to obesity and sedentary lifestyle, leading to insufficient glucose uptake.

• Hyperglycemia: Insufficient insulin action results in elevated blood glucose levels, as glucose cannot efficiently enter cells. This persistent hyperglycemia causes damage to blood vessels, nerves, and organs over time.

• Key complication: Chronic hyperglycemia leads to microvascular complications like retinopathy, nephropathy, and neuropathy, and macrovascular issues such as cardiovascular disease, highlighting the importance of blood glucose management and lifestyle modifications in preventing severe outcomes.

Patient Profile

Demographics:

56-year-old male, construction worker

History:

• Key past medical history: Type 2 Diabetes diagnosed 8 years ago, hypertension, hyperlipidemia

• Current medications: Metformin, Lisinopril, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing numbness and tingling in the feet

• Key symptoms: Frequent urination, excessive thirst, fatigue, blurred vision, slow-healing sores

• Vital signs: Blood pressure 150/95 mmHg, heart rate 92 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, blood glucose level 210 mg/dL

Section 1

New Diagnostic Results:

Following the initial assessment, the healthcare team ordered a comprehensive set of diagnostic tests to further evaluate the patient's condition and identify any developing complications. The lab results revealed a hemoglobin A1c level of 9.2%, indicating poor long-term blood glucose control. Additionally, a urine microalbumin test showed elevated levels of albumin, suggesting early nephropathy, a microvascular complication of diabetes. The lipid panel results were concerning, with an LDL cholesterol level of 160 mg/dL and HDL cholesterol at 35 mg/dL, highlighting suboptimal management of hyperlipidemia.

Moreover, a detailed foot examination confirmed the presence of peripheral neuropathy. The monofilament test showed diminished sensation in both feet, increasing the patient's risk for unnoticed injuries and ulcers. This finding correlates with the patient's chief complaint of numbness and tingling. An ophthalmology referral was made after fundoscopy revealed signs of diabetic retinopathy, characterized by microaneurysms and cotton wool spots in the retina.

These diagnostic results underscore the need for a more aggressive management plan addressing both hyperglycemia and associated risk factors to prevent the progression of complications. The healthcare team discussed the importance of lifestyle modifications with the patient, emphasizing dietary changes, increased physical activity, and smoking cessation. They also considered potential adjustments to his current medication regimen, including the addition of insulin therapy, to better manage his blood glucose levels and mitigate further risks of cardiovascular and renal complications.

Section 2

Following the discussion of diagnostic results, the healthcare team initiated a more aggressive management plan for the patient. This included starting the patient on a basal-bolus insulin regimen to improve glycemic control, alongside a statin to address hyperlipidemia. The patient was educated on insulin administration, the importance of monitoring blood glucose levels, and recognizing hypoglycemia symptoms. Additionally, the patient received dietary counseling focused on carbohydrate counting and the benefits of a Mediterranean-style diet to improve lipid profiles and glucose levels. A follow-up appointment was scheduled for two weeks to assess the effectiveness of these interventions and monitor for potential side effects.

Two weeks later, during the follow-up visit, the patient reported adhering to the new regimen but had experienced episodes of hypoglycemia, particularly before lunch and bedtime. His blood glucose log indicated several readings below 70 mg/dL. The patient also mentioned feeling fatigued and having trouble concentrating. On examination, his blood pressure was 148/86 mmHg, with a heart rate of 82 bpm, and he had lost four pounds since the last visit. The team recognized the risk of overtreating hyperglycemia and adjusted the insulin regimen by reducing the pre-meal rapid-acting insulin doses and reinforcing the importance of balanced meals and snacks to prevent hypoglycemia.

The team also noted that the patient's lipid levels had not improved significantly, despite adherence to the statin, suggesting the need for further evaluation of medication effectiveness or lifestyle adherence. They planned to re-evaluate the patient's lipid panel in another four weeks and considered the potential addition of a fibrate or omega-3 supplement if necessary. The ongoing foot care education was reiterated, emphasizing daily foot inspections to prevent complications from peripheral neuropathy. The patient was encouraged to maintain open communication with healthcare providers to address any concerns promptly, ensuring a proactive approach to managing his diabetes and its complications.

Section 3

Two weeks after the insulin regimen adjustment, the patient returned for another follow-up. During this visit, he reported an improvement in hypoglycemic episodes, with only one mild episode occurring in the past week, which he managed promptly with glucose tablets. However, he continued to experience persistent fatigue and difficulty concentrating. A thorough review of his blood glucose log revealed better glycemic stability, with most readings now within the target range of 80-130 mg/dL pre-meal. Despite these improvements, he expressed concern over new symptoms, including tingling and numbness in his feet, which raised the suspicion of progressing peripheral neuropathy.

The healthcare team conducted a series of tests to evaluate the patient's overall status and response to the interventions. His blood pressure had improved slightly to 142/84 mmHg, and his weight remained stable. However, the lipid panel revealed that his LDL cholesterol levels were still above the target range at 145 mg/dL, and his triglycerides were elevated at 210 mg/dL, indicating that the current statin therapy might not be sufficient. Additionally, a comprehensive metabolic panel showed a slight increase in liver enzymes, raising concerns about possible side effects from the medication.

Recognizing the need for further intervention, the team decided to explore additional options to address the patient's dyslipidemia. After discussing the risks and benefits, they opted to add an omega-3 supplement to the patient's regimen, while continuing to monitor liver function closely. The patient was also referred to a neurologist for further evaluation of the neuropathic symptoms. The team emphasized the importance of ongoing foot care and encouraged the patient to keep a detailed symptom diary to aid in identifying patterns and triggers. These measures aimed to enhance the patient's quality of life and prevent the progression of complications, while setting the stage for a comprehensive reassessment at the next follow-up.

Section 4

Two weeks later, the patient returned for a follow-up appointment, reporting some changes in his symptoms and overall health status. He noted a slight reduction in the tingling sensation in his feet, although numbness persisted. His fatigue had improved marginally, but he still experienced intermittent difficulty concentrating. The symptom diary he maintained revealed no significant patterns or triggers, but it highlighted occasional late-night snacking, which he admitted could be affecting his energy levels. On assessment, his vital signs were stable, with a blood pressure reading of 138/82 mmHg and a heart rate of 78 bpm. His weight was unchanged, and his blood glucose logs showed continued stability, maintaining the target range.

The neurologist's evaluation and subsequent nerve conduction studies confirmed the presence of mild peripheral neuropathy, likely secondary to his diabetes. They recommended starting a low-dose gabapentin to manage neuropathic pain and advised increasing vitamin B12 intake as a precautionary measure, given its role in nerve health. Meanwhile, the addition of omega-3 supplements appeared to have positively influenced his lipid profile. A repeat lipid panel showed a decrease in LDL cholesterol to 130 mg/dL and triglycerides to 180 mg/dL, indicating a favorable response. Liver enzymes, however, remained slightly elevated, necessitating further monitoring.

As the healthcare team reviewed these findings, they emphasized the importance of continuing the current regimen, including dietary modifications to further address dyslipidemia. They encouraged the patient to remain vigilant with foot care and to promptly report any new or worsening symptoms. The team planned for another follow-up visit in four weeks to reassess his neuropathy and lipid levels, and to determine whether additional adjustments to his treatment plan would be necessary. The patient left the clinic with a renewed sense of optimism, recognizing the importance of these comprehensive management strategies in mitigating the progression of his diabetes-related complications.

Section 5

Four weeks later, the patient returned for his scheduled follow-up visit, reporting mixed progress. He noted that while the tingling in his feet had continued to diminish, he was experiencing increased episodes of dizziness and occasional blurred vision, particularly in the mornings. These symptoms raised concerns for the healthcare team, prompting a thorough review of his current medications, dietary habits, and recent activities.

Upon initial assessment, the patient's vital signs were mostly stable, but his blood pressure had increased slightly to 142/86 mmHg. His heart rate remained consistent at 76 bpm, and his weight was largely unchanged. However, a repeat fasting blood glucose test revealed a subtle upward trend, with readings averaging slightly above the target range at 160 mg/dL. This prompted further investigation into his glycemic control and lifestyle factors that might be contributing to these changes.

The team decided to conduct additional diagnostic tests, including a hemoglobin A1c test, which showed an increase to 8.2%, indicating suboptimal long-term glucose control. Given these findings, the healthcare team suspected that the patient's occasional late-night snacking and potential inconsistencies in medication adherence might be impacting his overall metabolic balance. As a result, they reinforced the importance of maintaining a consistent eating schedule, adhering strictly to his medication regimen, and monitoring his blood glucose levels more frequently. They also discussed the possibility of introducing a long-acting insulin to better manage his blood sugar levels if necessary. The patient was encouraged to regularly check his blood pressure at home and to report any further changes in his symptoms, especially concerning his vision and dizziness, to address potential diabetic retinopathy or other complications promptly.